HFS
VRTX icon

Hughes Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Hughes Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.46K Buy
10
+5
+100% +$2.33K ﹤0.01% 444
2025
Q4 		$2.27K Buy
5
+1
+25% +$431 ﹤0.01% 522
2025
Q3 		$1.69K Sell
4
-2
-33% -$836 ﹤0.01% 593
2025
Q2 		$2.31K Sell
6
-4
-40% -$1.84K ﹤0.01% 520
2025
Q1 		$4.85K Buy
+10
New +$4.66K ﹤0.01% 409

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hughes Financial Services's VRTX Position: Q1 2026 in Review

Hughes Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 100% in Q1 2026, buying an estimated $2.33K and bringing the position to 10 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Hughes Financial Services first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.85K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Hughes Financial Services held 10 shares of Vertex Pharmaceuticals worth $4.46K as of Q1 2026.
  • Hughes Financial Services bought 5 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.33K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q1 2026, its #444 holding.
  • Hughes Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Hughes Financial Services's Vertex Pharmaceuticals position peaked at $4.85K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Hughes Financial Services's 13F filing for Q1 2026, filed 29 Apr 2026.